Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

Ariadne Bosman, Andrea Palermo, Julien Vanderhulst, Suzanne M.Jan De Beur, Seiji Fukumoto, Salvatore Minisola, Weibo Xia, Jean Jacques Body, M. Carola Zillikens*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Scopus)
3 Downloads (Pure)

Abstract

Tumor-induced osteomalacia (TIO) is a rare and largely underdiagnosed paraneoplastic condition. Previous reviews often reported incomplete data on clinical aspects, diagnosis or prognosis. The aim of this study was to present a systematic clinical review of all published cases of TIO. A search was conducted in Pubmed, Embase, Web of Science from inception until April 23rd, 2020. We selected case reports and case series of patients diagnosed with TIO, with information on tumor localization and serum phosphate concentration. Two reviewers independently extracted data on biochemical and clinical characteristics including bone involvement, tumor localization and treatment. 468 articles with 895 unique TIO cases were included. Median age was 46 years (range 9 months–90 years) and 58.3% were males. Hypophosphatemia and inappropriately low or normal 1,25-dihydroxyvitamin D levels, characteristic for TIO, were present in 98% of cases. Median tumor size was 2.7 cm (range 0.5 to 25.0 cm). Serum fibroblast growth factor 23 was related to tumor size (r = 0.344, P < 0.001). In 32% of the cases the tumor was detected by physical examination. Data on bone phenotype confirmed skeletal involvement: 62% of cases with BMD data had a T-score of the lumbar spine ≤ − 2.5 (n = 61/99) and a fracture was reported in at least 39% of all cases (n = 346/895). Diagnostic delay was longer than 2 years in more than 80% of cases. 10% were reported to be malignant at histology. In conclusion, TIO is a debilitating disease characterized by a long diagnostic delay leading to metabolic disturbances and skeletal impairment. Increasing awareness of TIO should decrease its diagnostic delay and the clinical consequences.

Original languageEnglish
Pages (from-to)367-379
Number of pages13
JournalCalcified Tissue International
Volume111
Issue number4
DOIs
Publication statusPublished - Oct 2022

Bibliographical note

Publisher Copyright: © 2022, The Author(s).

Fingerprint

Dive into the research topics of 'Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases'. Together they form a unique fingerprint.

Cite this